Previous Close | 1.0200 |
Open | 1.0100 |
Bid | 0.9817 x 200 |
Ask | 0.9918 x 600 |
Day's Range | 0.9720 - 1.0200 |
52 Week Range | 0.7100 - 1.9600 |
Volume | |
Avg. Volume | 1,536,096 |
Market Cap | 172.67M |
Beta (5Y Monthly) | 1.05 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Rigel (RIGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The analysts might have been a bit too bullish on Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ), given that the company...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2024. At this time, […]